MRNA – Moderna, Inc.
Moderna, Inc.MRNA
$35.53Name : Moderna, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $13,708,042,240.00
EPSttm : -9.28
Moderna, Inc.
$35.53
5.34%$1.80Float Short %
11.92
Margin Of Safety %
Put/Call OI Ratio
0.84
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
2.71
Price
35.54
Target Price
53.9
Analyst Recom
2.82
Performance Q
-10.07
Relative Volume
1.96
Beta
1.83
Ticker: MRNA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | MRNA | 42.4 | 0.86 | 0.59 | 667198 |
| 2025-01-24 | MRNA | 41.3 | 0.84 | 0.34 | 724803 |
| 2025-01-27 | MRNA | 41.65 | 0.79 | 0.38 | 708699 |
| 2025-01-28 | MRNA | 44.85 | 0.77 | 0.31 | 735523 |
| 2025-01-29 | MRNA | 40.69 | 0.75 | 0.36 | 763781 |
| 2025-01-30 | MRNA | 41.06 | 0.73 | 0.23 | 798729 |
| 2025-01-31 | MRNA | 39.42 | 0.68 | 0.64 | 841281 |
| 2025-02-03 | MRNA | 36.6 | 0.78 | 0.58 | 720405 |
| 2025-02-04 | MRNA | 34.15 | 0.81 | 0.50 | 750094 |
| 2025-02-05 | MRNA | 34.97 | 0.82 | 0.33 | 789357 |
| 2025-02-06 | MRNA | 33.62 | 0.79 | 0.34 | 823614 |
| 2025-02-07 | MRNA | 32.6 | 0.74 | 0.73 | 850255 |
| 2025-02-10 | MRNA | 31.85 | 0.84 | 0.49 | 764132 |
| 2025-02-11 | MRNA | 31 | 0.83 | 1.00 | 794938 |
| 2025-02-12 | MRNA | 30.54 | 0.83 | 0.74 | 825895 |
| 2025-02-13 | MRNA | 31.94 | 0.83 | 0.78 | 852872 |
| 2025-02-14 | MRNA | 32.99 | 0.82 | 0.51 | 898340 |
| 2025-02-18 | MRNA | 35.76 | 0.86 | 0.25 | 830814 |
| 2025-02-19 | MRNA | 35.91 | 0.83 | 0.41 | 874783 |
| 2025-02-20 | MRNA | 33.75 | 0.83 | 0.84 | 889269 |
| 2025-02-21 | MRNA | 35.53 | 0.84 | 0.17 | 891727 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | MRNA | 42.39 | -589.5 | -2027.9 | -9.06 |
| 2025-01-24 | MRNA | 41.39 | -589.5 | -1290.4 | -9.06 |
| 2025-01-27 | MRNA | 41.68 | -593.1 | -1461.6 | -9.06 |
| 2025-01-28 | MRNA | 44.94 | -593.1 | -1875.8 | -9.06 |
| 2025-01-29 | MRNA | 40.70 | -598.0 | -904.2 | -9.06 |
| 2025-01-30 | MRNA | 41.04 | -598.0 | -1469.5 | -9.06 |
| 2025-01-31 | MRNA | 39.48 | -587.0 | -1204.8 | -9.06 |
| 2025-02-03 | MRNA | 36.55 | -590.2 | -994.9 | -9.06 |
| 2025-02-04 | MRNA | 34.17 | -590.2 | -1017.2 | -9.06 |
| 2025-02-05 | MRNA | 35.00 | -590.2 | -1581.2 | -9.06 |
| 2025-02-06 | MRNA | 33.63 | -590.2 | -1178.5 | -9.06 |
| 2025-02-07 | MRNA | 32.61 | -590.2 | -1229.3 | -9.06 |
| 2025-02-10 | MRNA | 31.87 | -590.2 | -1274.2 | -9.06 |
| 2025-02-11 | MRNA | 30.92 | -590.2 | -1222.1 | -9.06 |
| 2025-02-12 | MRNA | 30.54 | -590.2 | -1335.9 | -9.06 |
| 2025-02-13 | MRNA | 31.92 | -590.2 | -1744.7 | -9.06 |
| 2025-02-14 | MRNA | 32.99 | -590.2 | -1652.3 | -9.06 |
| 2025-02-18 | MRNA | 35.76 | 1.5 | -2523.6 | -10.12 |
| 2025-02-19 | MRNA | 35.90 | 1.5 | -2080.8 | -10.13 |
| 2025-02-20 | MRNA | 33.74 | 1.2 | -1608.4 | -10.15 |
| 2025-02-21 | MRNA | 35.54 | 1.2 | -2807.2 | -10.15 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | MRNA | -0.09 | -0.43 | 11.03 |
| 2025-01-24 | MRNA | -0.09 | -0.43 | 11.03 |
| 2025-01-27 | MRNA | -0.06 | -0.38 | 11.03 |
| 2025-01-28 | MRNA | -0.06 | -0.38 | 12.53 |
| 2025-01-29 | MRNA | -0.06 | -0.38 | 12.53 |
| 2025-01-30 | MRNA | -0.06 | -0.38 | 12.53 |
| 2025-01-31 | MRNA | -0.06 | -0.38 | 12.53 |
| 2025-02-03 | MRNA | -0.02 | -0.96 | 12.53 |
| 2025-02-04 | MRNA | -0.02 | -0.96 | 12.53 |
| 2025-02-05 | MRNA | -0.02 | -0.96 | 12.53 |
| 2025-02-06 | MRNA | -0.02 | -0.96 | 12.53 |
| 2025-02-07 | MRNA | -0.02 | -0.96 | 12.53 |
| 2025-02-10 | MRNA | -0.02 | -2.63 | 12.54 |
| 2025-02-11 | MRNA | -0.02 | -2.63 | 12.54 |
| 2025-02-12 | MRNA | -0.02 | -2.63 | 11.84 |
| 2025-02-13 | MRNA | -0.02 | -2.63 | 11.84 |
| 2025-02-14 | MRNA | -0.02 | -2.63 | 11.84 |
| 2025-02-18 | MRNA | -0.02 | -2.62 | 11.83 |
| 2025-02-19 | MRNA | -0.02 | -2.62 | 11.92 |
| 2025-02-20 | MRNA | -0.02 | -2.62 | 11.92 |
| 2025-02-21 | MRNA | -0.02 | -2.62 | 11.92 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-3.09
Avg. EPS Est. Next Quarter
-3.01
Insider Transactions
-0.02
Institutional Transactions
-2.62
Beta
1.83
Average Sales Estimate Current Quarter
175
Average Sales Estimate Next Quarter
160
Fair Value
Quality Score
46
Growth Score
39
Sentiment Score
81
Actual DrawDown %
92.9
Max Drawdown 5-Year %
-93.7
Target Price
53.9
P/E
Forward P/E
PEG
P/S
4.23
P/B
1.15
P/Free Cash Flow
EPS
-9.28
Average EPS Est. Cur. Y
-10.15
EPS Next Y. (Est.)
-7.44
Target Price Estimates Raised
Target Price Estimates Lowered
3
Profit Margin
-110.04
Relative Volume
1.96
Return on Equity vs Sector %
-37.9
Return on Equity vs Industry %
-22.3
EPS 1 7Days Diff
-1.1
EPS 1 30Days Diff
-1.13
EBIT Estimation
-2807.2
Moderna, Inc.Sector: Healthcare
Industry: Biotechnology
Employees:
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
stock quote shares MRNA – Moderna, Inc. Stock Price stock today
news today MRNA – Moderna, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRNA – Moderna, Inc. yahoo finance google finance
stock history MRNA – Moderna, Inc. invest stock market
stock prices MRNA premarket after hours
ticker MRNA fair value insiders trading